Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

NYSE:BIO

251.56

+0.91 (+0.36%)

4:03:41 PM EDT: $244.19 -7.37 (-2.93%)

Market Cap (Intraday)	6.87B
Current PE	N/A
Forward PE	28.88
2yr Forward PE	25.88

See more stats

Estimates Current Quarter

Revenue	$615.64 Million
Adjusted EPS	$1.76

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Stock, NYSE:BIO

1000 Alfred Nobel Drive, Hercules, California 94547

United States of America

Phone: +1.510.724.7000

Number of Employees: 7700

http://www.bio-rad.com

Description

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.